First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA ApprovalWhite Bear Lake, Minnesota--(Newsfile Corp.

Financial support to prepare the submission of the Phase 2 clinical trial application for NFL-102 expected in mid-2026 Strengthening ...

Vans Warped Tour announced full lineup for the Aug. 21-22 stop in Montreal, which will feature Atreyu, Yellowcard, Sublime, ...

Logan Graham, the leader of the red team, recalled the bioweapons scare as an example of the challenges Anthropic faces at a pivotal moment for the company and the world. Anthropic is the frontier AI ...

As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot ...

Plenty of new dramas to enjoy this week, from the return of The Capture and Ellis to a new adaptation of A Woman of Substance – plus Claudia Winkleman hosts her own chatshow in Graham Norton’s slot.

Eli Lilly (LLY) stock under spotlight with $3B China investment, orforglipron approval filing, and LillyConnect platform launch. Analysts maintain bullish outlook.